PATH looks to recover to 25-28 area
PATH and other growth stocks might benefit from a potential FED halt-buy long duration.
PATH is set to benefit from it as it is a revolutionary industry, RPA and the growth rate of its revenues is still above 20%, even though many companies from the industry lost in revenue growth steam.
Technically, it crossed 200MA and consolidated for a while with a potential to break above 20 into 25-28 area.
PATH is set to benefit from it as it is a revolutionary industry, RPA and the growth rate of its revenues is still above 20%, even though many companies from the industry lost in revenue growth steam.
Technically, it crossed 200MA and consolidated for a while with a potential to break above 20 into 25-28 area.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.